ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
RSMDF is expected to report earnings to rise 6.16% to 27 cents per share on January 22
Q4'25
Est.
$0.27
Q3'25
Est.
$0.25
Q2'25
Beat
by $0.01
Q1'25
Est.
$0.24
Q4'24
Beat
by $0.01
The last earnings report on October 30 showed earnings per share of 25 cents, beating the estimate of 25 cents. With 198.96K shares outstanding, the current market capitalization sits at 36.91B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RSMDF showed earnings on October 30, 2025. You can read more about the earnings report here.